Colorectal Cancer Clinical Trials

38 trials recruiting in Canada.

Cancer

Recruiting Drug Device Behavioral Older adults Healthy volunteers

2 trials

Only a few results?

Someone at Concord can look with you.

Comparing 4 approaches for stage III colon cancer

Explore this study →

There are 4 groups in this study. Group A, the comparison group, receives one or more of: Signatera test, mFOLFOX6 3-6 month and CAPOX 3 month. Group B receives Signatera test. Group C, the comparison group, receives one or more of: Signatera test, mFOLFOX6 6 month and CAPOX 6 month. …and 1 more groups.

Sites in Toronto, Montreal and 24 more cities

Phase 2
4 groups
Sites in Calgary, Prince George and 23 more cities
Recruiting

Official title: Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease

Stage III Colon Cancer · NRG Oncology

Testing Nivolumab with HDRBET for locally advanced rectal cancer

Explore this study →

Everyone in this study receives Nivolumab, together with one or more of: HDRBET and Total Mesorectal Excision (TME).

One site, in Montreal

Phase 2
1 group
One site, in Montreal
Recruiting

Official title: Brachytherapy Followed by Nivolumab Prior to Surgery in Rectal Cancer

Locally Advanced Rectal Cancer · Dr. Te Vuong

Looking for the closest fit?

Get matched →

Ask someone to look with you

Whether or not the results above are what you were looking for, someone at Concord can search with you.

Get notified when a matching trial opens

We'll watch for Colorectal Cancer trials near you.

← Back to all conditions

Concord provides information support only. Trial listings come from public registries; eligibility is always determined by the trial site and your care team.